Company Filing History:
Years Active: 2016
Title: The Innovations of Tao Luo
Introduction
Tao Luo is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is recognized for its potential applications in medical research and treatment.
Latest Patents
Tao Luo holds a patent for the invention titled "P28GANK monoclonal antibody and peptides for preparation thereof and use thereof." This invention provides the sequences of two polypeptides comprising the amino acid sequences as shown in SEQ ID NO:1 and SEQ ID NO:2. These sequences can be utilized for the preparation of monoclonal antibodies against human p28. The invention also details the monoclonal antibodies against human p28 and their various uses. He has 1 patent to his name.
Career Highlights
Tao Luo is affiliated with the Second Military Medical University, which is part of the People's Liberation Army. His role at this institution allows him to engage in cutting-edge research and development in the medical field. His work has the potential to impact various therapeutic areas.
Collaborations
Some of his notable coworkers include Hongyang Wang and Yao Liang Chen. Their collaborative efforts contribute to the advancement of research and innovation in their respective fields.
Conclusion
Tao Luo's contributions to biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and treatment options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.